REPLIGEN CORP Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REPLIGEN CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REPLIGEN CORP for March 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2021 | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | Sell | S | 196.88 | 1,400 | 275,632 | 37,140 | 38.5 K to 37.1 K (-3.63 %) |
| Mar 16 2021 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Gift | G | 0.00 | 170 | 0 | 1,294 | 1.5 K to 1.3 K (-11.61 %) |
| Mar 12 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 194.08 | 235 | 45,609 | 212,762 | 213 K to 212.8 K (-0.11 %) |
| Mar 12 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 193.30 | 227 | 43,879 | 212,997 | 213.2 K to 213 K (-0.11 %) |
| Mar 12 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 192.17 | 1,378 | 264,810 | 213,224 | 214.6 K to 213.2 K (-0.64 %) |
| Mar 12 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 191.19 | 1,081 | 206,676 | 214,602 | 215.7 K to 214.6 K (-0.50 %) |
| Mar 12 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 190.17 | 4,096 | 778,936 | 215,683 | 219.8 K to 215.7 K (-1.86 %) |
| Mar 12 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 188.77 | 1,171 | 221,050 | 219,779 | 221 K to 219.8 K (-0.53 %) |
| Mar 12 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 188.06 | 914 | 171,887 | 220,950 | 221.9 K to 221 K (-0.41 %) |
| Mar 12 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Option Exercise | M | 59.52 | 150 | 8,928 | 3,911 | |
| Mar 12 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Option Exercise | M | 33.87 | 5,850 | 198,140 | 0 | |
| Mar 12 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Option Exercise | M | 33.05 | 2,000 | 66,100 | 2,000 | |
| Mar 12 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Sell | S | 192.13 | 1,004 | 192,899 | 25,265 | 26.3 K to 25.3 K (-3.82 %) |
| Mar 12 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Sell | S | 191.33 | 642 | 122,834 | 26,269 | 26.9 K to 26.3 K (-2.39 %) |
| Mar 12 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Sell | S | 190.08 | 6,354 | 1,207,768 | 26,911 | 33.3 K to 26.9 K (-19.10 %) |
| Mar 12 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Buy | M | 59.52 | 150 | 8,928 | 33,265 | 33.1 K to 33.3 K (+0.45 %) |
| Mar 12 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Buy | M | 33.87 | 5,850 | 198,140 | 33,115 | 27.3 K to 33.1 K (+21.46 %) |
| Mar 12 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Buy | M | 33.05 | 2,000 | 66,100 | 27,265 | 25.3 K to 27.3 K (+7.92 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 185.22 | 1,633 | 302,464 | 221,864 | 223.5 K to 221.9 K (-0.73 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 185.91 | 4,746 | 882,329 | 223,497 | 228.2 K to 223.5 K (-2.08 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 186.90 | 4,271 | 798,250 | 228,243 | 232.5 K to 228.2 K (-1.84 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 187.48 | 595 | 111,551 | 232,514 | 233.1 K to 232.5 K (-0.26 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 193.45 | 6,193 | 1,198,036 | 233,109 | 239.3 K to 233.1 K (-2.59 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 194.43 | 2,125 | 413,164 | 239,302 | 241.4 K to 239.3 K (-0.88 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 195.54 | 1,082 | 211,574 | 241,427 | 242.5 K to 241.4 K (-0.45 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 196.44 | 461 | 90,559 | 242,509 | 243 K to 242.5 K (-0.19 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Sell | S | 197.94 | 794 | 157,164 | 242,970 | 243.8 K to 243 K (-0.33 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 189.75 | 600 | 113,850 | 32,363 | 33 K to 32.4 K (-1.82 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 190.45 | 603 | 114,841 | 32,963 | 33.6 K to 33 K (-1.80 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 191.43 | 500 | 95,715 | 33,566 | 34.1 K to 33.6 K (-1.47 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 192.54 | 900 | 173,286 | 34,066 | 35 K to 34.1 K (-2.57 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 193.72 | 242 | 46,880 | 34,966 | 35.2 K to 35 K (-0.69 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 196.30 | 500 | 98,150 | 35,208 | 35.7 K to 35.2 K (-1.40 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 197.86 | 200 | 39,572 | 35,708 | 35.9 K to 35.7 K (-0.56 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Sell | S | 190.06 | 700 | 133,042 | 25,265 | 26 K to 25.3 K (-2.70 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Sell | S | 191.20 | 600 | 114,720 | 25,965 | 26.6 K to 26 K (-2.26 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Sell | S | 192.24 | 350 | 67,284 | 26,565 | 26.9 K to 26.6 K (-1.30 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Sell | S | 194.30 | 25 | 4,858 | 26,915 | 26.9 K to 26.9 K (-0.09 %) |
| Mar 08 2021 | RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | Sell | S | 196.23 | 400 | 78,492 | 26,940 | 27.3 K to 26.9 K (-1.46 %) |
| Mar 04 2021 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 26.12 | 1,000 | 26,120 | 0 | |
| Mar 04 2021 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 205.00 | 1,000 | 205,000 | 1,464 | 2.5 K to 1.5 K (-40.58 %) |
| Mar 04 2021 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 26.12 | 1,000 | 26,120 | 2,464 | 1.5 K to 2.5 K (+68.31 %) |